For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/impacting-copd-outcomes-challenges-and-opportunities-9534

Summary
Join Dr. Fernando Martinez as he welcomes Dr. David Au and Dr. Jamuna Krishnan to The NACE Clinical Highlights Show. This podcast highlights the research of Dr. Au and Dr. Krishnan, discussing the important translation of their research into pulmonology clinical practice.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Identify ways to overcome provider and practice-based healthcare disparities in the management of patients with COPD

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0 hours of pharmacology.

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.

Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/dd5-your-questions-on-menopausal-vasomotor-symptoms-9542

Summary
Dr. Leana Wen guides Dr. Genevieve Neal-Perry through five of your most common questions on menopausal VMS. Get a better understanding of the evolution in the science surrounding the biology of menopause, and discuss new and emerging non-hormonal treatment options for women with menopausal hot flashes and night sweats. Keep the conversation going with this, the third podcast in the series.

Learning Objectives
Upon completion of this activity, learners should be able to:

• Discuss the biology of menopausal vasomotor symptoms (VMS)
• Integrate new and emerging agents into the treatment of women with menopausal VMS, based on patient characteristics and preferences

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0 hours of pharmacology.

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an independent medical educational grant from Astellas Pharma Global Development, Inc.

Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/a-better-understanding-advances-in-severe-asthma-9530

Summary
In this CME/CE podcast, join NACE and the Association for Pulmonary Advanced Practice Providers as Nurse Practitioner Corinne Young and Dr. Diego Maselli take a deep dive into the latest advances in severe asthma treatment. Join in a dynamic discussion on groundbreaking research into IL-13 agents and mucus production, TSLP, mast cell activity, and more. Discover the experts’ take on the latest evolutions in our understanding of asthma treatments, and gain practical insights into how these innovations are shaping clinical practice.

Learning Objectives
Upon completion of this activity, learners should be able to:

• Review evolving concepts in the understanding, evaluation, and treatments of severe asthma and their implications on management

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0 hours of pharmacology.

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.

Please visit http://naceonline.com to engage in more live and on demand CME/CE content.